REGENCY PHARMA LIMITED — Empagliflozin Importer Profile
Pharmaceutical Importer · #1 buyer for Empagliflozin · $989.2K import value · 603 shipments · MAURITIUS · DGFT Verified
REGENCY PHARMA LIMITED is the #1 importer of Empagliflozin from India with $989.2K in import value and 603 verified shipments. REGENCY PHARMA LIMITED holds a 15.0% market share in Empagliflozin imports based in MAURITIUS. The company sources from 3 verified suppliers across 39 formulations shipped to 1 country. Overall, REGENCY PHARMA LIMITED imports 16 pharmaceutical products worth $8.9M across 9 therapeutic categories.
REGENCY PHARMA LIMITED — Empagliflozin Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Empagliflozin to REGENCY PHARMA LIMITED?
Verified from 603 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| SAVA HEALTHCARE LIMITED | $575.1K | 522 | 58.1% |
| HEXA HEALTH CARE PRIVATE LIMITED | $326.1K | 56 | 33.0% |
| HEXA HEALTHCARE PRIVATE LIMITED | $88.1K | 25 | 8.9% |
REGENCY PHARMA LIMITED sources Empagliflozin from 3 verified Indian suppliers based on 603 customs records. The primary supplier is SAVA HEALTHCARE LIMITED accounting for 58.1% of imports.
How Does REGENCY PHARMA LIMITED Compare to Nearest Empagliflozin Importers?
Buyers ranked immediately above and below #1 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | REGENCY PHARMA LIMITED ★ | MAURITIUS | $1.0M | 603 | $1.7K |
| 2 | BPOST INTERNATIONAL | BELGIUM | $696.9K | 716 | $973 |
| 3 | REGENCY PHARMA LTD | MAURITIUS | $338.7K | 85 | $4.0K |
REGENCY PHARMA LIMITED ranks #1 among 236 Empagliflozin importers from India. Average shipment value of $1.7K compared to the market average of $14.7K. The closest competitors by value are BPOST INTERNATIONAL and REGENCY PHARMA LTD.
Where Does REGENCY PHARMA LIMITED Import Empagliflozin To?
Destination countries from 603 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| MAURITIUS | $989.2K | 603 | 100.0% |
REGENCY PHARMA LIMITED imports Empagliflozin to 1 country. The primary destination is MAURITIUS receiving 100.0% of shipments worth $989.2K.
What Empagliflozin Formulations Does REGENCY PHARMA LIMITED Import?
| Formulation | Value | Shipments |
|---|---|---|
| JARDIANCE 25MG 90 TAB EMPAGLIFLOZIN | $175.8K | 57 |
| JARDIANCE 25 MG 90 TAB EMPAGLIFLOZIN | $135.4K | 16 |
| JARDIANCE 10 MG 90 TAB EMPAGLIFLOZIN | $125.9K | 13 |
| JARDIANCE 10MG 90 TAB EMPAGLIFLOZIN | $116.3K | 47 |
| GIBTULIO 10MG 90 TAB EMPAGLIFLOZIN | $73.2K | 144 |
| GIBTULIO 25MG 90 TAB EMPAGLIFLOZIN | $61.2K | 113 |
| GIBTULIO 10 MG 90 TAB EMPAGLIFLOZIN | $57.2K | 18 |
| GIBTULIO 25 MG 90 TAB EMPAGLIFLOZIN | $35.5K | 11 |
| PHARMACEUTICAL PRODUCT EMPAGLIFLOZIN TABLETS 10 MG Each film coated tablet contains Empagliflozin 10 mg Excip | $29.8K | 1 |
| JARDIANCE 25 MG 90 TAB EMPAGLIFLOZINNOS | $29.6K | 6 |
REGENCY PHARMA LIMITED imports 39 distinct Empagliflozin formulations from India. The top formulation is JARDIANCE 25MG 90 TAB EMPAGLIFLOZIN with 57 shipments worth $175.8K.
Who Are the Top Buyers of Empagliflozin from India and How Much Does REGENCY PHARMA LIMITED Import?
India exported $3.5M worth of Empagliflozin through 3,528 shipments from 170 suppliers to 75 countries, serving 236 buyers globally. REGENCY PHARMA LIMITED imports $989.2K of this total, accounting for 15.0% of India's Empagliflozin exports with 603 shipments from MAURITIUS. This is verified from 603 customs shipment records covering 39 distinct formulations.
What Is the Average Order Value for REGENCY PHARMA LIMITED's Empagliflozin Imports?
REGENCY PHARMA LIMITED's average Empagliflozin order value is $1.6K per consignment, based on 603 shipments totaling $989.2K. REGENCY PHARMA LIMITED is based in MAURITIUS and ranks #1 among all Empagliflozin importers from India by value. The company sources from 3 verified suppliers in India.
Who Supplies Empagliflozin to REGENCY PHARMA LIMITED?
REGENCY PHARMA LIMITED sources Empagliflozin from 3 verified Indian suppliers: SAVA HEALTHCARE LIMITED ($575.1K, 58.1%), HEXA HEALTH CARE PRIVATE LIMITED ($326.1K, 33.0%), HEXA HEALTHCARE PRIVATE LIMITED ($88.1K, 8.9%). This is based on 603 customs records.
How Does REGENCY PHARMA LIMITED Compare to Other Empagliflozin Importers?
REGENCY PHARMA LIMITED ranks #1 among 236 Empagliflozin importers from India with a 15.0% market share. The top 3 importers are REGENCY PHARMA LIMITED ($1.0M), BPOST INTERNATIONAL ($696.9K), REGENCY PHARMA LTD ($338.7K). REGENCY PHARMA LIMITED processed 603 shipments from MAURITIUS.
About REGENCY PHARMA LIMITED
REGENCY PHARMA LIMITED imports 16 products worth $8.9M. Beyond Empagliflozin, top products include Ivermectin, Dapagliflozin, Apixaban, Extract, Semaglutide. View the complete REGENCY PHARMA LIMITED profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Empagliflozin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Empagliflozin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: REGENCY PHARMA LIMITED matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as REGENCY PHARMA LIMITED's capped import value divided by total capped export value for Empagliflozin across all Indian exporters.
- 5.Verified Records: This page is backed by 603 individual customs records matching REGENCY PHARMA LIMITED importing Empagliflozin, covering 39 formulations from 3 verified suppliers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 75+ countries, 236+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Empagliflozin Import Data for REGENCY PHARMA LIMITED
Access order-level details, pricing data, supplier connections, and competitive analysis for REGENCY PHARMA LIMITED's Empagliflozin imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
REGENCY PHARMA LIMITED
Full Company Profile →
16 products · $8.9M total trade · 9 categories
REGENCY PHARMA LIMITED × Empagliflozin
Verified from customs records
Company Overview
Top Products by REGENCY PHARMA LIMITED
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for REGENCY PHARMA LIMITED.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Empagliflozin. For current order-level data, contact TransData Nexus.